Tekla Capital Management LLC

Tekla Capital Management LLC

Tekla Capital Management LLC

Date Founded



100 Federal Street 19th Floor Boston MA United States 02110

Type of Company


Employees (Worldwide)



Investment Services & Portfolio Management
Hospitals & Patient Services
Accounting & Financial Services
Private Equity & Venture Capital

Company Description

Tekla Capital Management primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries.

Contact Data
Trying to get in touch with decision makers at Tekla Capital Management LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Head Trader

Fund Advisor

Senior Vice President of Research

Senior Vice President of Research

Manager-Fund Administration

Chief Financial Officer

General Partner

Fund Advisor

Fund Advisor

Board of Trustees

Director-Tumor Biology Steele Lab at The Massachusetts General Hospital

President & Chief Executive Officer at Tekla Capital Management LLC

Paths to Tekla Capital Management LLC
Potential Connections via
Relationship Science
Tekla Capital Management LLC
Recent Transactions
Details Hidden

Tekla World Healthcare Fund issued USD Common Stock

Details Hidden

Hambrecht & Quist Group, Inc. purchases Tekla Capital Management LLC from JPMorgan Chase & Co.

Transaction Clients
Investment Advisor

Advised on Tekla World Healthcare Fund issued USD Common Stock

Transaction Advisors
Investment Advisor

Advised onHambrecht & Quist Group, Inc. purchases Tekla Capital Management LLC from JPMorgan Chase & Co.

Non-Profit Donations & Grants
$2,500 - $4,999
Details Hidden

Magellan Biosciences, Inc. engages in the manufacture of medical devices for point-of-care systems, clinical laboratory instruments, and analytical laboratory. The company was founded on May 4, 2005 and is headquartered in North Billerica, MA.

Details Hidden

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Details Hidden

Pyxis Oncology, Inc. develops antibody therapeutics. The company was founded by David Steinberg, Shaan Gandhi, and John Flavin and is headquartered in Boston, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tekla Capital Management LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tekla Capital Management LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Tekla Capital Management LLC.